Skip to Main Content

Paper Details

Physician interpretation of genomic test results and treatment selection.
Cancer
10
2018
Cancer, KRAS, genomic, in actionable genes, patients
Author NameAffiliation
Kenna R Mills ShawSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Kenna R Mills ShawThe University of Texas MD Anderson Cancer Center
Kenna R Mills ShawSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Kenna R Mills ShawThe University of Texas MD Anderson Cancer Center
Elmer V BernstamThe University of Texas Health Science Center at Houston
Elmer V BernstamMcGovern Medical School, The University of Texas Health Science Center at Houston
Mark J RoutbortThe University of Texas MD Anderson Cancer Center
Gordon B MillsSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Gordon B MillsThe University of Texas MD Anderson Cancer Center
Gordon B MillsSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Gordon B MillsThe University of Texas MD Anderson Cancer Center
Funda Meric-BernstamSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
  • 1 - 14

Datasets

Release 1.2